Genetic variation at position -1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis

Journal of Neuroimmunology

Volumn 104, Issue 1, 2000, Pages 98-100

  Mäurer, Mathias ^a   Kruse, Niels ^a   Giess, Ralf ^a   Toyka, Klaus V ^a   Rieckmann, Peter ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Genetic polymorphism; Interleukin 10; Multiple sclerosis

Indexed keywords

INTERLEUKIN 10;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ALLELES; AMINO ACID SEQUENCE; DISABILITY EVALUATION; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-10; MULTIPLE SCLEROSIS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; VARIATION (GENETICS);

EID: 0343750675     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00256-8     Document Type: Article

References (11)

1. Boxel-Dezaire A.H.H., Hoff S.C.J., vanOosten B.W., Verweij C.L., Dräger A.M., Ader H.J., vanHouwelingen J.C., Barkhof F., Polman C.H., Nagelkerken L. Decreased interleukin-10 and increased interleukin-12p40 mRNA are associated with disease activity and characterize different disease stages in multiple sclerosis. Ann. Neurol. 45:1999;695-703.
2. Crawley E., Kay R., Sillibourne J., Patel P., Hutchison I., Woo P. Polymorphic haplotypes of the IL10 5′ flanking region determine variable IL10 transcription and are associated with particular phenotypes of juvenile idiopathic arthritis. Eur. Cytokine Network. 9:1998;504.
3. Kruse N., Pette M., Toyka K., Rieckmann P. Quantification of cytokine mRNA expression by RT PCR in samples of previously frozen blood. J. Immunlogical Methods. 210:1997;195-203.
4. Kruse N., Mäurer M., Rieckmann P. Determination of a genetic dimorphism within the human TNFa promotor using the 5′nuclease essay. Eur. Cytokine Network. 9:1998;504.
5. Kube D., Platzer C., Knethen A., Straub H., Bohlen H., Hafner M., Tesch H. Isolation of the human interleukin 10 promotor. Characterisation of the promotor activity in Burkitts lymphoma cell lines. Cytokine. 7:1995;1-7.
6. Lim S., Crawley E., Woo P., Barnes P.J. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 353:1998;113.
7. Moore K.W., O'Gara A., Waal Malefyt R., Vieira P., Mosmann T.R. Interleukin 10. Annu. Rev. Immunol. 11:1993;165-190.
8. Navikas V., Link H. Cytokines and the pathogenesis of multiple sclerosis. J. Neurosci. Res. 45:1996;322-333.
9. Rieckmann P., Albrecht M., Kitze B. Cytokine mRNA levels in mononuclear cells from patients with multiple sclerosis. Neurology. 44:1994;1523-1526.
10. Romano-Spica V., Georgiou P., Suzuki H., Papas T.S., Bhat N.K. Role of ETS1 in IL-2 gene expression. J. Immunol. 154:1995;2724.
11. Turner D.M., Williams D.M., Sankaran D., Lazarus M., Sinnott P.J., Hutchinson I.V. An investigation of polymorphism in the interleukin-10 gene promotor. Eur. J. Immunogenet. 24:1997;1-8.